|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
MARSTACIMAB |
B02BX11 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
GARADACIMAB |
B06AC07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
IMETELSTAT |
L01XX80 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
LAZERTINIB |
L01EB09 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
RO
|
I
|
15-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
ETRASIMOD |
L04AE05 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
RO
|
I
|
15-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
RO
|
I
|
15-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
RO
|
I
|
15-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
RO
|
I
|
03-03-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
VAMOROLONE |
H02AB18 |
RO
|
I
|
14-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
FARICIMAB |
S01LA09 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
SOMATROGON |
H01AC08 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
REMDESIVIR |
J05AB16 |
RO
|
I
|
|
EMEA/H/C/005622 |
03-07-2020 |
VALID
|
|
ASCIMINIB |
L01EA06 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
ARTESUNATE |
P01BE03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
MITAPIVAT |
B06AX04 |
RO
|
I
|
03-10-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE |
R03AL12 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005518 |
03-07-2020 |
VALID
|
|
INDACATEROL AND MOMETASONE |
R03AK14 |
RO
|
I
|
05-10-2020 |
EMEA/H/C/005516 |
30-05-2020 |
VALID
|